Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7THC

Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B25

7THC の概要
エントリーDOI10.2210/pdb7thc/pdb
関連するPDBエントリー7TGS 7TGT 7TGU 7TGV 7TH1 7TH6 7TH7
分子名称Peptidyl-prolyl cis-trans isomerase F, mitochondrial, 3-(4'-{[(4S,7S,11R,13E,19S)-19-{[2-(2-aminoethoxy)ethyl]carbamoyl}-7-benzyl-3,6,12,15,21-pentaoxo-1,3,4,5,6,7,8,9,10,12,15,16,17,18,19,20,21,22-octadecahydro-2H-7,11-methano-2,5,11,16,20-benzopentaazacyclotetracosin-4-yl]methyl}[1,1'-biphenyl]-4-yl)prop-2-ynoic acid (3 entities in total)
機能のキーワードoxidative stress, necrosis, mitochondrial permeability, isomerase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計18519.12
構造登録者
Rangwala, A.M.,Thakur, M.K.,Seeliger, M.A.,Peterson, A.A.,Liu, D.R. (登録日: 2022-01-10, 公開日: 2022-08-24, 最終更新日: 2023-10-18)
主引用文献Peterson, A.A.,Rangwala, A.M.,Thakur, M.K.,Ward, P.S.,Hung, C.,Outhwaite, I.R.,Chan, A.I.,Usanov, D.L.,Mootha, V.K.,Seeliger, M.A.,Liu, D.R.
Discovery and molecular basis of subtype-selective cyclophilin inhibitors.
Nat.Chem.Biol., 18:1184-1195, 2022
Cited by
PubMed Abstract: Although cyclophilins are attractive targets for probing biology and therapeutic intervention, no subtype-selective cyclophilin inhibitors have been described. We discovered novel cyclophilin inhibitors from the in vitro selection of a DNA-templated library of 256,000 drug-like macrocycles for cyclophilin D (CypD) affinity. Iterated macrocycle engineering guided by ten X-ray co-crystal structures yielded potent and selective inhibitors (half maximal inhibitory concentration (IC) = 10 nM) that bind the active site of CypD and also make novel interactions with non-conserved residues in the S2 pocket, an adjacent exo-site. The resulting macrocycles inhibit CypD activity with 21- to >10,000-fold selectivity over other cyclophilins and inhibit mitochondrial permeability transition pore opening in isolated mitochondria. We further exploited S2 pocket interactions to develop the first cyclophilin E (CypE)-selective inhibitor, which forms a reversible covalent bond with a CypE S2 pocket lysine, and exhibits 30- to >4,000-fold selectivity over other cyclophilins. These findings reveal a strategy to generate isoform-selective small-molecule cyclophilin modulators, advancing their suitability as targets for biological investigation and therapeutic development.
PubMed: 36163383
DOI: 10.1038/s41589-022-01116-1
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.57 Å)
構造検証レポート
Validation report summary of 7thc
検証レポート(詳細版)ダウンロードをダウンロード

237735

件を2025-06-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon